Biophysical characterization of DNA aptamer interactions with vascular endothelial growth factor

The binding of a DNA aptamer (5′‐CCGTCTTCCAGACAAGAGTGCAGGG‐3′) to recombinant human vascular endothelial growth factor (VEGF165) was characterized using surface plasmon resonance (SPR), fluorescence anisotropy and isothermal titration calorimetry (ITC). Results from both fluorescence anisotropy and ITC indicated that a single aptamer molecule binds to each VEGF homodimer, unlike other VEGF inhibitors that exhibit 2(ligand):1(VEGF homodimer) stoichiometry. In addition, ITC revealed that the association of the aptamer to VEGF at 20°C is enthalpically driven, with an unfavorable entropy contribution. SPR kinetic studies, with careful control of possible mass transfer effects, demonstrated that the aptamer binds to VEGF with an association rate constant kon = 4.79 ± 0.03 × 104 M−1 s−1 and a dissociation rate constant koff = 5.21 ± 0.02 × 10−4 s−1 at 25°C. Key recognition hot‐spots were determined by a combination of aptamer sequence substitutions, truncations, and extensions. Most single‐nucleotide substitutions, particularly within an mfold‐predicted stem, suppress binding, whereas those within a predicted loop have a minimal effect. The 5′‐end of the aptamer plays a key role in VEGF recognition, as a single‐nucleotide truncation abolished VEGF binding. Conversely, an 11‐fold increase in the association rate (and affinity) is observed with a single cytosine nucleotide extension, due to pairing of the 3′‐GGG with 5′‐CCC in the extended aptamer. Our approach effectively maps the secondary structural elements in the free aptamer, which present the unpaired interface for high affinity VEGF recognition. These data demonstrate that a directed binding analysis can be used in concert with library screening to characterize and improve aptamer/ligand recognition. © 2008 Wiley Periodicals, Inc. Biopolymers 91: 145–156, 2009.

[1]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[2]  D. Guyer,et al.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.

[3]  Victor Okhonin,et al.  Selection of smart aptamers by methods of kinetic capillary electrophoresis. , 2006, Analytical chemistry.

[4]  P. Romaniuk,et al.  Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1. , 2001, Biochemistry.

[5]  Michael R. Green,et al.  HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA , 1991, Cell.

[6]  J. Witz Kinetic analysis of analyte binding by optical biosensors: hydrodynamic penetration of the analyte flow into the polymer matrix reduces the influence of mass transport. , 1999, Analytical biochemistry.

[7]  S. Nishikawa,et al.  Novel Approach to Analyzing RNA Aptamer-Protein Interactions: Toward Further Applications of Aptamers , 2006, Journal of biomolecular screening.

[8]  G. Másson,et al.  Determination of active concentrations and association and dissociation rate constants of interacting biomolecules: an analytical solution to the theory for kinetic and mass transport limitations in biosensor technology and its experimental verification. , 2002, Biochemistry.

[9]  J. SantaLucia,et al.  The thermodynamics of DNA structural motifs. , 2004, Annual review of biophysics and biomolecular structure.

[10]  T. Lohman,et al.  Ion effects on ligand-nucleic acid interactions. , 1976, Journal of molecular biology.

[11]  O. Uhlenbeck,et al.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. , 1987, Nucleic acids research.

[12]  R K Jain,et al.  Fluorescence photobleaching with spatial Fourier analysis: measurement of diffusion in light-scattering media. , 1993, Biophysical journal.

[13]  D. Myszka,et al.  Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.

[14]  A. Minton,et al.  Analysis of mass transport-limited binding kinetics in evanescent wave biosensors. , 1996, Analytical biochemistry.

[15]  P. V. von Hippel,et al.  Facilitated Target Location in Biological Systems* , 2022 .

[16]  Neal W. Woodbury,et al.  Exploring the sequence space of a DNA aptamer using microarrays , 2007, Nucleic acids research.

[17]  T. Fitzwater,et al.  Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor , 1997, Nature Biotechnology.

[18]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[19]  D G Myszka,et al.  Extending the range of rate constants available from BIACORE: interpreting mass transport-influenced binding data. , 1998, Biophysical journal.

[20]  M. Siddiqui,et al.  Pegaptanib , 2012, Drugs.

[21]  Kazunori Ikebukuro,et al.  Aptamer selection based on inhibitory activity using an evolution-mimicking algorithm. , 2006, Biochemical and biophysical research communications.

[22]  Giridharan Gokulrangan,et al.  DNA aptamer-based bioanalysis of IgE by fluorescence anisotropy. , 2005, Analytical chemistry.

[23]  N. Janjić,et al.  Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. , 1999, The American journal of pathology.

[24]  A. D. de Vos,et al.  Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Varki,et al.  DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. , 1996, The Journal of clinical investigation.

[26]  C. Milstein,et al.  Conformational isomerism and the diversity of antibodies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A D Ellington,et al.  Toward Automated Nucleic Acid Enzyme Selection , 2001, Biological chemistry.

[28]  A. D. de Vos,et al.  Crystal structure of the complex between VEGF and a receptor-blocking peptide. , 1998, Biochemistry.

[29]  I. Tinoco,et al.  How RNA folds. , 1999, Journal of molecular biology.

[30]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[31]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[32]  J. Janin The kinetics of protein‐protein recognition , 1997, Proteins.

[33]  J. Szostak,et al.  Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures , 1992, Nature.

[34]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[35]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[36]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[37]  S. Titolo,et al.  Characterization of the DNA-Binding Properties of the Origin-Binding Domain of Simian Virus 40 Large T Antigen by Fluorescence Anisotropy , 2003, Journal of Virology.

[38]  T. Lohman,et al.  Na+ effects on transitions of DNA and polynucleotides of variable linear charge density , 1976, Biopolymers.

[39]  Susan M Lea,et al.  Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1. , 2005, RNA.

[40]  Jean Sturm,et al.  Persistence Length of Single-Stranded DNA , 1997 .

[41]  R. Willson,et al.  Association and dissociation kinetics of anti-hen egg lysozyme monoclonal antibodies HyHEL-5 and HyHEL-10. , 1998, Biophysical journal.

[42]  L. Christensen Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. , 1997, Analytical biochemistry.

[43]  R. Rich,et al.  Survey of the year 2004 commercial optical biosensor literature , 2005, Journal of molecular recognition : JMR.

[44]  R W Glaser,et al.  Antigen-antibody binding and mass transport by convection and diffusion to a surface: a two-dimensional computer model of binding and dissociation kinetics. , 1993, Analytical biochemistry.

[45]  L. Gold,et al.  RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Shi-jie Chen,et al.  Nucleic acid helix stability: effects of salt concentration, cation valence and size, and chain length. , 2006, Biophysical journal.

[47]  J. Clark,et al.  Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. , 1988, Nucleic acids research.

[48]  Michael Musheev,et al.  Non-SELEX selection of aptamers. , 2006, Journal of the American Chemical Society.

[49]  J. SantaLucia,et al.  A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Christy F Landes,et al.  Dynamics of an anti-VEGF DNA aptamer: a single-molecule study. , 2008, Biochemical and biophysical research communications.

[51]  A. Pardi,et al.  A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Stockley,et al.  Probing the kinetics of formation of the bacteriophage MS2 translational operator complex: identification of a protein conformer unable to bind RNA. , 2001, Journal of molecular biology.

[53]  P. Richardson,et al.  An improved method for the in vitro evolution of aptamers and applications in protein detection and purification. , 2003, Nucleic acids research.

[54]  Charles Eigenbrot,et al.  Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor , 1997, Cell.

[55]  N. Janjić,et al.  Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. , 1994, Biochemistry.